Change over period: —
NSE · DCMSHRIRAM
DCMSHRIRAM
-32.4% from the 52-week high · +0.6% above the low
DCM Shriram Ltd. engages in the business of agri-rural, value added, and chlor-vinyl. The company is headquartered in New Delhi, Delhi and currently employs 5,803 full-time employees. The firm's segments include Fertilisers, which manufactures urea; Chloro-Vinyl, which manufactures poly-vinyl chloride, carbide, and chlor alkali products; Shriram Farm solutions, which is engaged in trading of super-phosphate, other fertilizers, seeds and pesticides; Sugar, which manufactures sugar, ethanol and co-generation of power; Bioseed, which produces hybrid seeds, and Others, which includes window systems, cement, rural retail and plaster of paris. Its Agri-Rural Business includes sugar, urea and hybrid seeds, farm inputs merchandising such as, crop care and specialty chemicals. Its Chlor-Vinyl Business includes caustic soda, chlorine, calcium carbide, PVC resins, PVC compounds, power and cement. The company has a value-added business, Fenesta Building Systems, which manufactures unplasticized polyvinyl chloride (UPVC) windows and doors. The company has manufacturing facilities in Rajasthan and Gujarat.
The short version. DCMSHRIRAM reported revenue of ₹4,151 crore for Sep 2026, up 20.9% from a year earlier. Net profit was ₹105 crore (down 33.5% year on year). Return on equity was 11.1% in Mar 2026. Promoter holding was 66.52% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
DCMSHRIRAM trades 32.4% below its 52-week high and 0.6% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹4,151 cr.
Sep 2026 net profit of ₹105 cr.
2.1 pts lower than a year earlier.
Revenue compounded at 5.8% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4151 | 3785 | 3373 | 4003 | 3432 | 3455 | 3019 | 3519 |
| Net profit | 105 | 693 | 370 | 212 | 158 | 113 | 179 | 262 |
| Net margin % | 2.5 | 18.3 | 11.0 | 5.3 | 4.6 | 3.3 | 5.9 | 7.4 |
| EPS (₹) | 6.72 | 44.47 | 23.72 | 13.6 | 10.13 | 7.27 | 11.47 | 16.81 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14264 | 12741 | 11431 | 12080 | 9849 | 8308 | 7767 | 7771 |
| Net profit | 853 | 604 | 447 | 911 | 1067 | 674 | 722 | 904 |
| Net margin % | 6.0 | 4.7 | 3.9 | 7.5 | 10.8 | 8.1 | 9.3 | 11.6 |
| EPS (₹) | 54.73 | 38.75 | 28.67 | 58.41 | 68.45 | 43.22 | 46.31 | 57.99 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 11.1% in Mar 2026; debt to equity is 0.36.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 11.1 | 8.6 | 6.9 | 14.7 |
| Return on capital % | 11.2 | 11.2 | 8.9 | 17.9 |
| EBITDA margin % | 11.6 | 11.4 | 9.4 | 14.1 |
| Net margin % | 5.9 | 4.7 | 3.9 | 7.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 5.8% | 11.5% |
| Profit CAGR | -2.1% | 4.8% |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.02 pts over 8 quarters.
Up 0.67 pts over 8 quarters.
+3 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 0.0 |
| FII | 4.0 | 4.1 | 4.13 | 3.97 | 3.97 | 3.97 | 3.89 | 3.98 | -0.02 |
| DII | 7.65 | 7.76 | 8.05 | 8.25 | 8.31 | 8.56 | 8.46 | 8.32 | +0.67 |
| Public | 21.11 | 20.81 | 20.52 | 20.53 | 20.49 | 20.24 | 20.44 | 20.5 | -0.61 |
Mutual fund holdings · Oct 2026
15 schemes hold this stock
12 the month before.
- UTI Large & Mid Cap Fund1.0% of NAV
- HDFC BSE India Sector Leaders Index Fund0.9% of NAV
- UTI BSE India Sector Leaders Exchange Traded Fund0.9% of NAV
- UTI BSE India Sector Leaders Index Fund0.9% of NAV
- Bandhan BSE India Sector Leaders Index Fund0.9% of NAV
- Axis BSE India Sector Leaders Index Fund0.9% of NAV
- UTI Aggressive Hybrid Fund0.76% of NAV
- UTI Retirement Fund0.44% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for DCMSHRIRAM are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Diversified stocks
Quick answers
Common questions about DCMSHRIRAM
What is the DCMSHRIRAM share price?
DCMSHRIRAM (DCMSHRIRAM) last closed at ₹888.60, up 1.03% on the day. Its 52-week range is ₹874.00 to ₹1,301.80.
What is the market cap of DCMSHRIRAM?
DCMSHRIRAM has a market capitalisation of about ₹14,055 crore. Its price-to-earnings ratio is 10.0.
How are DCMSHRIRAM's latest results?
DCMSHRIRAM reported revenue of ₹4,151 crore for Sep 2026, up 20.9% from a year earlier. Net profit was ₹105 crore (down 33.5% year on year). Return on equity was 11.1% in Mar 2026. Promoter holding was 66.52% in Sep 2026, up 0.00 points over 8 quarters.
Who owns DCMSHRIRAM?
As of Sep 2026, shareholding was: Promoter 66.52%, FII 3.98%, DII 8.32%, Public 20.5%.
How many mutual funds hold DCMSHRIRAM?
15 mutual fund schemes held DCMSHRIRAM in October 2026. That compares with 12 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 23 Jan 2026 · Interim Dividend - Rs. 3.6
- 03 Nov 2025 · Interim Dividend - Rs. 3.6
- 05 Aug 2025 · Final Dividend - Rs. 3.4
- 24 Jan 2025 · Interim Dividend - Rs. 3.6
- 11 Nov 2024 · Interim Dividend - Rs. 2
- 09 Jul 2024 · Final Dividend - Rs. 2.6
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.